Vivani Medical, Inc. (VANI) stock
VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.05+0.03 (+2.94%)
Close on Nov 17, 2026Market cap $94.71MP/E –Yield –
Vivani Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Vivani Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$25.30M. For fiscal 2025 it was -$24.32M. The highest annual figure on record is -$10.95M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.32M | – |
| FY2024 | Dec 31, 2024 | -$20.79M | – |
| FY2023 | Dec 31, 2023 | -$23.70M | – |
| FY2022 | Dec 31, 2022 | -$18.79M | – |
| FY2021 | Dec 31, 2021 | -$10.95M | – |
| FY2020 | Dec 31, 2020 | -$16.82M | – |
| FY2019 | Dec 31, 2019 | -$27.63M | – |
| FY2018 | Dec 31, 2018 | -$29.81M | – |
| FY2017 | Dec 31, 2017 | -$23.95M | – |
| FY2016 | Dec 31, 2016 | -$25.07M | – |
| FY2015 | Dec 31, 2015 | -$20.55M | – |
| FY2014 | Dec 31, 2014 | -$17.09M | – |
| FY2013 | Dec 31, 2013 | -$17.43M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.72M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.35M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.16M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.80M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.70M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.97M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.96M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.45M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.18M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.96M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.19M | – |
| Q1 FY2021 | Mar 31, 2021 | -$778.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.65M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.39M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.46M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.64M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.73M | – |
| Q3 FY2018 | Sep 30, 2018 | -$7.46M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.85M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.78M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.71M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.68M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.96M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.60M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.02M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.95M | – |
See a number that looks wrong?